LERMA PUERTAS, ENRIQUE FGS
elerma@santpau.cat
Bague Rosell, Silvia FGS
Catasus Cols, Lluis FGS
Clua Gonzalez, Agustin FGS
Espinosa Mariscal, Iñigo FGS
Ferre Figa, Malena FGS
Fumagalli, Caterina FGS
Fuste Chimisana, Victoria FGS
Gallardo Alcañiz, Alberto FGS
Gonzalez Vidal, Alan FGS
Gutierrez Montalban, Raquel FGS
Lopez Vilaro, Laura FGS
Manzotti, Carolina FGS
Mozos Rocafort, Ana FGS
Orellana Fernandez, Ruth Joaquina FGS
Szafranska, Justyna FGS
(JIF 2023)
-Álamo P, Parladé E, Favaro MTP, Gallardo A, Mendoza R, Ferreira LCS, Roher N, Mangues R, Villaverde A, Vázquez E. Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins. ACS Applied Materials & Interfaces. 2023; 15(33). DOI:10.1021/acsami.3c08643. PMID:37614001. IF:8,500 (Q1/2D). Document type: Article.
-Álvarez Álvarez R, Manzano A, Agra Pujol C, Artigas Raventós V, Correa R, Cruz Jurado J, Fernandez JA, Garcia Del Muro X, Gonzalez JA, Hindi N, Lozano Lominchar P, Martínez-Trufero J, Méndez R, Muñoz M, Muñoz Casares C, Orbis Castellanos F, Orellana Fernandez R, Paniagua González M, Redondo A, Valverde Morales C, Asencio JM. Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS). Cancers. 2023; 15(12):3194. DOI: 10.3390/cancers15123194. PMID: 37370803. IF:4,500 (Q1/3D). Document type: Review.
-Álvarez R, Dols O, El Bounasri S, López L, Trujillo JC, Reyes D, Suárez X, Cortés E, Illa I, Gallardo E. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2):e200085. DOI:10.1212/NXI.0000000000200085. PMID:36697230. IF:8,300 (Q1/1D). Document type: Article.
-Arqueros C, Salazar J, Gallardo A, Andrés M, Tibau A, Bell OL, Artigas A, Lasa A, Cajal T, Lerma E, Barnadas A. Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines. 2023; 11(12):3231. DOI:10.3390/biomedicines11123231. PMID:38137452. IF:3,900 (Q1/3D). Document type: Article.
-Barca EG, Tomas L, Esteve A, Rodriguez M, Gato L, Alonso R, Garcia AM, Cordoba R, Monter A, Bastos M, Burgues JMB, Sayas MJ, Alegria MCV, Sanchez JJ, Pellicer MR, Henriquez HDL, de Ona R, Cabezudo ME, Infante MS, Hernandez J, Sanz R, Blanco O, Mozos A, Climent F, Piris MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. AMERICAN JOURNAL OF HEMATOLOGY. 2023; 98(6):E134-E138. DOI:10.1002/ajh.26904. PMID:36882876. IF:10,100 (Q1/1D). Document type: Letter.
-Barrabes C, Arandes J, Armillas L, Posada RA, Koptseva I, Fumagalli C, Pinol D, Salleras M. Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors. BRITISH JOURNAL OF DERMATOLOGY. 2023; 189(4). DOI:10.1093/bjd/ljad206. PMID:37378960. IF:11,000 (Q1/1D). Document type: Letter.
-Carmona E, Aguado M, Tubau C, Sánchez S, Mozos A, Sullivan I, Spertino J. Epidermolysis bullosa acquisita induced by atezolizumab. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023; DOI:10.1111/ddg.15203. PMID:37658659. IF:5,500 (Q1/1D). Document type: Letter.
-Cosio BG, Shafiek H, Iglesias A, Mosteiro M, Gonzalez A, Rodríguez M, García M, Busto E, Martin J, Mejías L, Benito A, López L, Gómez C. Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(8). DOI:10.1016/j.arbres.2023.05.014. PMID:37414638. IF:8,700 (Q1/1D). Document type: Article.
-D’Angelo E, Espinosa I, Felicioni L, Buttitta F, Prat J. Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor. HUMAN PATHOLOGY. 2023; 141. DOI:10.1016/j.humpath.2023.08.010. PMID:37673346. IF:2,700 (Q2/4D). Document type: Article.
-Escuin D, López L, Bell O, Mora J, García B, Moral A, Clos M, Boronat L, Arqueros C, Barnadas A. Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(17):13293. DOI:10.3390/ijms241713293. PMID:37686099. IF:4,900 (Q1/3D). Document type: Article.
-Español P, Rovira R, Caruana P, Luna-Guibourg R, Soler C, Teixeira N, Rodríguez F, Gallardo A, Edwards M, Porta O, Gámez M, Sánchez O, Llurba E, Corchero JL, Céspedes MV. Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients. Gynecol Oncol. 2023 ;176:25-35. DOI:10.1016/j.ygyno.2023.06.019. PMID: 37437489. IF:4,500 (Q1/1D). Document Type: Article.
-Espinosa I, D’Angelo E, De Brot L, Prat J. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study. HUMAN PATHOLOGY. 2023; 135. DOI:10.1016/j.humpath.2023.02.006. PMID:36863690. IF:2,700 (Q2/4D). Document type: Article.
-Frezza AM, Stacchiotti S, Chibon F, Coindre JM, Italiano A, Romagnosa C, Bagué S, Dei AP, Braglia L, Palmerini E, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Brunello A, Blay JY, Beveridge RD, Lugowska I, Lesluyes T, Maestro R, Merlo FD, Casali PG, Gronchi A. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study. Cancer Medicine. 2023; 12(2). DOI:10.1002/cam4.5015. PMID:35848358. IF:2,900 (Q2/5D). Document type: Article.
-Fumagalli C, Orellana R, Ferre M, Gonzalez A, Catasus L, Vazquez T, Sebio A, Lopez A, Llauger J, Peiro A, Antonescu CR. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion. GENES CHROMOSOMES & CANCER. 2023; 63(1). DOI:10.1002/gcc.23215. PMID:38050902. IF:3,100 (Q2/4D). Document type: Article.
-Gené M, Cuatrecasas M, Amat I, Veiga JA, Fernández MJ, Fusté V, Tarragona J, Jurado I, Fernández R, Martínez C, Alenda C, Zac C, Ortega de la Obra P, Fernández MT, Esteller M, Musulen E. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(10):8655. DOI:10.3390/ijms24108655. PMID:37240002. IF:4,900 (Q1/3D). Document type: Article.
-León X, Bague S, Holgado A, Quer M, Terra X, Camacho M, Aviltes FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(6). DOI:10.1016/j.otorri.2023.05.001. IF:0,900 (Q3/8D). Document type: Article.
-Marti D, Gougol A, Gomez C, Jamali A, Abo A, Morales D, Jimenez A, Burns K, Bawa A, Hernandez A, Pujol C, Alvarado E, Szafranska J, Chiu WK, Villagrasa A, Ventura M, Gandicheruvu H, Lluch P, Chen HW, Rachakonda V, Duarte A, Bataller R. Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study. Eclinicalmedicine. 2023; 61:102046. DOI:10.1016/j.eclinm.2023.102046. PMID:37415844. IF:9,600 (Q1/1D). Document type: Article.
-Martinez C, Alba L, Carrasco LI, Serna N, Imedio L, Gallardo A, Casanova I, Unzueta U, Vazquez E, Mangues R, Villaverde A. Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles. BIOMEDICINE & PHARMACOTHERAPY. 2023; 164:114976. DOI:10.1016/j.biopha.2023.114976. PMID:37276641. IF:6,900 (Q1/1D). Document type: Article.
-Medina E, García A, Gallardo A, Álamo P, Alba L, Unzueta U, Villaverde A, Vázquez E, Casanova I, Mangues R. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers. 2023; 15(1):85. DOI:10.3390/cancers15010085. PMID:36612081. IF:4,500 (Q1/3D). Document type: Article.
-Navarro M, Estadella I, Benavente A, Orellana R, Petit A, Ferreres JC, Felipe A. The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel. Cancers. 2023; 15(10):2716. DOI:10.3390/cancers15102716. PMID:37345053. IF:4,500 (Q1/3D). Document type: Review.
-Nunez Y, Garcia A, Falgas A, Serna N, Sanchez L, Garrido A, Sierra J, Gallardo A, Unzueta U, Vazquez E, Villaverde A, Mangues R, Casanova I. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 2023; 15(3):727. DOI:10.3390/pharmaceutics15030727. PMID:36986589. IF:4,900 (Q1/2D). Document type: Article.
-Revilla G, Ruiz L, Vallverdu NF, Santamaria P, Moral A, Perez JI, Li CD, Fuste V, Lerma E, Corcoy R, Pitoia F, Escola JC, Mato E. Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13):11153. DOI:10.3390/ijms241311153. PMID:37446330. IF:4,900 (Q1/3D). Document type: Article.
-Rusiñol L, Mozos A, Yélamos O. Disseminated Monomorphic Pink Papules. JAMA Dermatology. 2023; 159(12). DOI:10.1001/jamadermatol.2023.3586. PMID:37938840. IF:11,500 (Q1/1D). Document type: Editorial Material.
-Sanchez L, Paul T, Martori C, Font J, Sanjurjo L, Aran G, Tellez E, Blanco J, Carrillo J, Ito M, Tuttolomondo M, Ditzel HJ, Fumagalli C, Tapia G, Sidorova J, Masnou H, Fernandez MA, Lozano JJ, Vilaplana C, Rodriguez A, Armengol C, Valledor AF, Kremer L, Sarriasa MR. Macrophage CD5L is a target for cancer immunotherapy. EBioMedicine. 2023; 91:104555. DOI:10.1016/j.ebiom.2023.104555. PMID:37054630. IF:9,700 (Q1/1D). Document type: Article.
-Serret Miralles P, Orellana Fernández R, Parra Parente T, García-Chamón Brígido RB, Carrera Salas R. Tumor de células gigantes óseo en arco costal, tratado con denosumab. Reporte de un caso [Giant cell tumour of bone in the rib cage treated with denosumab. A case report]. Rev Esp Patol. 2023; 56(2):119-123. DOI: 10.1016/j.patol.2021.04.002. PMID: 37061238. Document type: Article.
-Voltà E, Alba L, Serna N, Casanova I, López H, Gallardo A, Sánchez A, Villaverde A, Unzueta U, Vázquez E, Mangues R. High-precision targeting and destruction of cancer-associated PDGFR-ß(+) stromal fibroblasts through self-assembling, protein-only nanoparticles. Acta Biomaterialia. 2023; 170. DOI:10.1016/j.actbio.2023.09.001. PMID:37683965. IF:9,400 (Q1/1D). Document type: Article.
-Zampacorta C, Pasciuto MP, Ferro B, Lucidi A, Maestro AS, Espinosa I, D’Angelo E, Prat J. Placental site trophoblastic tumor (PSTT): a case report and review of the literature. Pathologica. 2023; 115(2)DOI:10.32074/1591-951X-873. PMID:37114629.Collet R, Olmedo G, Ruiz I, Martinez A, Rodriguez B, Bernal S, Kulisevsky J, Pagonabarraga J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8). DOI:10.1002/mdc3.13811. PMID:37635772. IF:2,600 (Q2/5D). Document type: Review.
(JIF 2022)